- Home
- TDG vs CAH Comparison
TDG vs CAH Comparison
Compare TDG & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TDG | CAH |
|---|---|---|
| Founded | 1993 | 1979 |
| Country | United States | United States |
| Employees | 16500 | N/A |
| Industry | Military/Government/Technical | Other Pharmaceuticals |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.5B | 55.6B |
| IPO Year | 2005 | 1994 |
Fundamental Metrics
Financial Performance| Metric | TDG | CAH |
|---|---|---|
| Price | $1,255.25 | $234.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 12 |
| Target Price | ★ $1,559.69 | $232.27 |
| AVG Volume (30 Days) | 429.2K | ★ 2.0M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | ★ 7.88% | 1.01% |
| EPS Growth | ★ 25.21 | 12.09 |
| EPS | ★ 25.20 | 7.23 |
| Revenue | $8,831,000,000.00 | ★ $254,248,000,000.00 |
| Revenue This Year | $15.19 | $17.36 |
| Revenue Next Year | $8.64 | $9.06 |
| P/E Ratio | $49.46 | ★ $31.99 |
| Revenue Growth | 11.22 | ★ 14.23 |
| 52 Week Low | $1,123.61 | $145.87 |
| 52 Week High | $1,463.03 | $258.30 |
Technical Indicators
Market Signals| Indicator | TDG | CAH |
|---|---|---|
| Relative Strength Index (RSI) | 50.32 | 52.35 |
| Support Level | $1,249.33 | $216.98 |
| Resistance Level | $1,283.44 | $243.21 |
| Average True Range (ATR) | 37.48 | 6.55 |
| MACD | -0.03 | -0.27 |
| Stochastic Oscillator | 28.80 | 28.31 |
Price Performance
Historical ComparisonAbout TDG Transdigm Group Incorporated
TransDigm manufactures and services a broad set of specialized parts for commercial and military aircraft. The firm has three segments: power and control, airframes, and a small nonaviation segment, which serves mostly off-road vehicles and mining equipment. It is an acquisitive holding company focused on buying up smaller firms that make proprietary aerospace products with substantial aftermarket revenue. TransDigm regularly employs financial leverage to amplify its operating results.
About CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.